INTRACTABLE EPILEPSY
(A company limited by guarantee)
Report and Financial Statements For the Period Ended 31 March 2023
Charity Number: 1199192 Company Registration Number: 13019024
Contents
Reference and administrative details of the charity, its Trustees and advisers......................................3 Report of the Trustees...........................................................................................................................4 Independent Examiner's Report to the Trustees....................................................................................7 Statement of Financial Activities for the period ended 31 March 2023.................................................8 Balance Sheet as at 31 March 2023.......................................................................................................9 Cashflow Statement for 31 March 2023...............................................................................................10 Notes forming part of the Financial Statements for the Period ended 31 March 2023..................11-15
Prepared by
2
Reference and administrative details of the charity, its Trustees and advisers
Members of the Council: Graham Howard Levy Ronald Jack Cowan MP Emily Carkeet Joanne Marjorie Justine Griffiths Karen Gray Chairman Graham Howard Levy Company Secretary: Joanne Griffiths
Registered office and Principal address: Fir Tree Barn Preston Road Crossmoor Preston PR4 3XB
Prepared by
3
The Report of the Trustees
The Trustees present their report and the financial statements of the charity for the year ended 31 March 2023 which are also prepared to meet the requirements for a directors’ report and accounts for Companies Act purposes.
The financial statements comply with the Charities Act 2011, the Companies Act 2006, the Articles of Association, and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015).
Structure, Governance and Management
Legal Status
The organisation is a charitable company limited by guarantee, incorporated on 15[th] Nov 2020 and registered as a charity on 06[th] June 2022. The company was established under a Memorandum of Association setting out the objects and powers of the charitable company and is governed under its Articles of Association.
Members of the Council
Members of the Council (who are directors for the purpose of company law and trustees for the purpose of charity law) who served during the year and up to the date of this report are set out on page 3. Potential new additions to the Council are considered by the existing members on the basis of the organisation’s needs.
Objectives and Activities
Principal activity and charitable status
The company is registered charity established to raise funds to help Families in need raise funds for Medication currently legal but not available on the NHS. Its registered charity number is 1199192 and its company registration number is 13019024.
The public benefit
The public Benefit is to raise funds to assist families who are financially suffering to pay for the necessary medication that can relieve their children's suffering.
Prepared by
4
Financial Review Reserves policy
Total reserves at 31 March 2023 amounted to £17,906 of which £17,906 were unrestricted funds and £nil restricted funds. This will be covered by income or capital.
The Trust recognizes the need for an adequate level of reserves, in particular given the uncertainties of funding and the frequent delays in the actual provision of the financial resources agreed by funding bodies. The current reserves policy is to hold a minimum of 4-6 months budgeted annual expenditure as reserves to cover core costs. At 31 March 2023 the free reserves of the company amounted to £17,906 which is comfortably in line with the reserves policy. The balance sheet is set out on page 9.
Risk Management Policy
Potential risks facing the Trusts are the uneven flow of project finance, the late payments of grants agreed for projects and the associated foreign exchange risk, where relevant. The former is most effectively managed by ensuring firstly that there are clear, unambiguous arrangements in place with a donor prior to substantive project development and secondly that the financial monitoring and reporting on projects is timely, thereby permitting prompt claims to donors. Foreign exchange risk will be minimized by prompt switching into the currency where the maximum costs are incurred.
Small Company Provisions
This report has been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act 2006.
Approve by the members of the Council on 3 1 /03/2025 and signed on their behalf by:
Graham Howard Levy
On behalf of the Council Members
Chairman
Member of Council
Prepared by
5
INTRACTABLE EPILEPSY
Statement of Financial Activities (incorporating an income and expenditure account) for the Period from 01[st] December 2021 to 31 March 2023
| Notes Income and endowments from: Donations and legacies 1 Charitable activities 2 Investments and other income 3 Total income and endowments Expenditure on: Raising funds 4 Charitable activities 4 Total expenditure Net income / (expenditure) for the year Net movement of funds Reconciliation of funds Total funds brought forward 12 Total funds carried forward |
Unrestricted Restricted Total Funds Total Funds Funds 2023 Funds 2023 2023 2021 £ £ £ £ 22,832 4,637 - - 22,832 4,637 5,021 - 12 - 12 - |
|---|---|
| 27,481 - 27,481 5,021 |
|
| 6,967 - 6,967 191 7,438 - 7,438 - |
|
| 14,405 - 14,405 191 |
|
| 13,076 - 13,076 4,830 |
|
| 13,076 - 13,076 4,830 |
|
| 4,830 - 4,830 - |
|
| 17,906 - 17,906 4830 |
Prepared by
6
INTRACTABLE EPILEPSY Balance Sheet as at 31 March 2023 (Company registration number 13019024)
| Notes Fixed Assets Tangible assets 8 Current Assets Debtors 9 Cash at bank and in hand 10 Creditors: Amounts falling due within one year 11 Net Current Assets Net Assets Unrestricted Funds 13 Restricted Funds 13 Total Funds |
2023 2021 £ £ - - 1,200 - 17,306 4830 18,506 4830 (600) - 17,906 4830 17,906 4830 17,906 4830 - - 17,906 4830 |
|---|---|
These financial statements have been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act 2006.
The Trustees consider that the charitable company is entitled to exemption from the requirement to have an audit under the provisions of section 477 of the Companies Act 2006 ("the Act") and members have not required the charitable company to obtain an audit for the year in question in accordance with section 476 of the Act.
The Trustees acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
Approved by the members of the Council on 3 1 /03/2025
and signed on their behalf by:
Graham Howard Levy
On behalf of the Council Members
Chairman
Member of Council
Prepared by
7
INTRACTABLE EPILEPSY
Cash Flow Statement for the period ended 31 March 2023
| Net cash flow from operating activities Cash flow from investing activities Interest received Purchase of tangible fixed asset Net cash flow from investing activities Net increase / (decrease) in cash and cash equivalents Cash and cash equivalents at start date 01 December 2021 Cash and cash equivalents at end date 31 March 2023 Cash and cash equivalents consist of: Cash at bank and in hand Cash and cash equivalents at end date 31 March 2023 Reconciliation of net income / (expenditure) to net cash flow from operating activities Net income / (expenditure) for year/period Interest receivable (Increase)/Decrease in debtors Increase/(Decrease) in creditors Net cash flow from operating activities |
2023 £ 2021 £ 12,464 4,830 12 - - - |
|---|---|
| 12 - |
|
| 12,476 4,830 4,830 - |
|
| 17,306 4,830 |
|
| 17,306 4,830 |
|
| 17,306 4,830 |
|
| 2023 2021 £ £ 13,076 4,830 (12) - (1200) - 600 - |
|
| 12,464 4,830 |
Prepared by
8
Notes forming part of the Financial Statements for the Year ended 31 March 2023
General information
The Intractable Epilepsy for Giving Children Their Lives Back is a charitable company, limited by guarantee, domiciled in England and Wales.
The registered office as detailed on page 3.
Company limited by guarantee
The company is limited by guarantee and does not have a share capital.
Accounting Policies
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP (FRS 102)) and the Companies Act 2006.
The Intractable Epilepsy for Giving Children Their Lives Back meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognized at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
The charitable company’s functional and presentational currency is GBP, rounded to the nearest GBP.
Going Concern
The charity has reported a cash inflow for the year of £12,464. The charity is currently self-financing, and the trustees are in the fortunate position that they do not rely on external finance to operate.
After reviewing the charity’s forecasts and projections the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. The charity therefore continues to adopt the going concern basis in preparing its financial statements.
Debtors and prepayments
Trade and other debtors are recognized at the settlement amount due after any trade discounts. Prepayments are valued at the amount prepaid net of any discounts.
Creditors and provisions
Creditors and provisions are recognized where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount to settle the obligation can be measured or estimated reliably.
Income
Income is recognized once the charitable company has entitlement to the funds, any performance conditions have been met, it is probable that the income will be received, and the amount can be measured reliably.
Income from grants, whether ‘capital’ grants or ‘revenue’ grants, is recognized when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received and the amount can be measured reliably and is not deferred.
Donations and legacies receivable for the general purposes of the charity are credited to ‘unrestricted funds’. Donations and legacies for purposes restricted by the wishes of the donor are presented in ‘restricted funds’.
Where legacies have been notified to the charity, or the charity is aware of the granting of probate, and the criteria for income recognition have not been met, then the legacy is treated as a contingent asset and disclosed if material
Prepared by
9
d
Interest is included when receivable and the amount can be measured reliably by the charity.
Expenditure
Expenditure is recognized once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required, and the amount of the obligation can be measured reliably. Expenditure is classified under the following activity headings:
-
Costs of raising funds comprise the costs of marketing.
-
Expenditure on charitable activities includes the costs of salaries, and other activities undertaken to further the purposes of the charity and their associated support costs.
-
Other expenditure represents those items not falling into any other heading.
Tangible Fixed Assets
Fixed assets with a cost price of more than £500 are capitalized at cost and depreciation is calculated on a straight- line basis over their useful economic life of 3 years.
Foreign Exchange
All foreign transaction gains and losses are determined using the date of the foreign transaction.
Funds
Unrestricted funds comprise incoming resources receivable or generated for the objectives of the charity without further specified purpose and are available as general funds.
Restricted funds are for the specific purpose specified by the donor and relevant expenditure is charged to the fund.
Financial instruments
The charitable company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognized at transaction value and subsequently measured at their settlement value.
Critical accounting judgements and key sources of estimation uncertainty
In preparing the financial statements, management is required to make estimates and assumptions which affect reported income, expenses, assets, liabilities and disclosure of contingent assets and liabilities. Use of available information and application of judgements are inherent in the formation of estimates, together with past experience and expectations of future events that are believed to be reasonable under the circumstances. Actual results in the future could differ from such estimates.
Management do not consider there to be any material accounting estimates or judgements that need disclosure in these financial statements.
Prepared by
10
d
1) Donations and legacies
| Donations | Unrestricted £ Restricted £ 2023 Total £ 2021 Total £ 22,832 - 22,832 5,021 |
|---|---|
| 22,832 - 22,832 5,021 |
Income from donations and legacies was £22,832 (2023 - £5,021) was attributable to unrestricted funds.
2) Incoming Resources from Activities to further the Charity’s Objectives
| Day Events Fundraising Websites Lottery Other Revenue |
Unrestricted £ Restricted £ 2023 Total £ 2021 Total £ 250 - 250 - 3,065 - 3,065 - 540 - 540 - 782 - 782 - |
|---|---|
| 4,637 - 4,637 - |
Income from charitable activities is all attributable to unrestricted funds in the current year .
3) Income from Investments
| Interest Received | Unrestricted £ Restricted £ 2023 Total £ 2021 Total £ 12 - 12 - |
|---|---|
| 12 - 12 - |
Income from investments was all attributable to unrestricted funds in the current and prior year.
4) Analysis of Expenditure on Charitable Activities
| Cost of Generating Funds Charitable Activities |
Activities undertaken directly £ Support costs £ 2023 Total £ 2021 Total £ 5,897 1,070 6,967 191 5,389 2,049 7,438 - |
|---|---|
11,286 3,11914,405 191 |
Prepared by
11
d
5) Employee Remuneration
| Payroll Details: Wages and Salaries Pension |
2023 Total £ 2021 Total £ - - - - |
|---|---|
| - - |
The total amount of employee benefits received by key management personnel is £nil (2021 - £nil).
6) Trustee Remuneration & Related Party Transactions
There were no related party transactions in the current year (2023 - none). No trustee received any remuneration or reimbursed expenses during the year (2021- £nil).
7)Taxation
As a charity, Intractable Epilepsy for Giving Children Their Lives Back is exempt from tax on income and gains to the extent that these are applied to its charitable objects. No tax charges have arisen in the Charity.
8) Tangible Fixed Assets
| Cost: At 1 December 2021 Disposals Additions At 31 March 2023 Accumulated Depreciation At 1 December 2021 Disposals Current year depreciation At 31 March 2023 Net book value At 31 March 2023 At 30 November 2021 |
Office Equipment Total £ £ - - - - - - |
|---|---|
| - - |
|
| - - - - - - |
|
| - - |
|
| - - |
|
| - - |
Prepared by
12
d
9) Debtors
| Trade debtors Prepayments Accrued Income 10) Cash at bank and in hand Bank and cash at hand 11) Creditors: Amounts Falling Due within One Year Trade Creditors Accruals and deferred income Taxation and social security Other Creditors |
2023 Total £ 2021 Total £ 1,200 - - - - - 1,200 - 2023 Total 2021 Total £ £ 17,306 4,830 17,306 4,830 2023 Total £ 2021 Total £ - - 600 - - - - - |
||
|---|---|---|---|
| 600 - |
10) Cash at bank and in hand
11) Creditors: Amounts Falling Due within One Year
The was no income deferred at the end of the year (2021: Nil).
Prepared by d
13
12) Movement in Funds
| Current year: Restricted Funds Unrestricted Funds Total Funds Prior Year: Restricted Funds Unrestricted Funds Total Funds |
At 1 December 2021 £ Incoming Resources £ Outgoing Resources £ Transfers £ At 31 March 2023 £ - - - - - 4,830 27,481 (14,405) - 17,906 |
|---|---|
| 4,830 27,481 (14,405) - 17,906 |
|
| At 15 Nov Incoming Outgoing At 30 Nov 2020 Resources Resources Transfers 2021 £ £ £ £ £ - - - - - - 5,021 (191) - 4,830 |
|
| - 5,021 (191) - 4,830 |
Prepared by
14
d
13) Analysis of net assets between funds
| Current year: Fund balances at31 March 2023are represented by: Tangible fixed assets Current assets Creditors: amounts falling due within one year Prior year: Fund balances at30 November 2021are represented by: Tangible fixed assets Current assets Creditors: amounts falling due within one year |
Unrestricted funds Restricted funds Total £ £ £ - - - 18,506 - 18,506 (600) - (600) |
|---|---|
| 17,906 - 17,906 |
|
| Unrestricted funds £ Restricted funds £ Total £ - - - 4,830 - 4,830 - - - |
|
| 4,830 - 4,830 |
Prepared by d
15